NCT01777646 Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01771640 Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS Status COMPLETED Phase PHASE1
NCT01759797 Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS Status COMPLETED Phase PHASE1
NCT01759784 Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS Status WITHDRAWN Phase PHASE1
NCT01758510 Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT01753076 Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT01730716 Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE2
NCT01709149 Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01641965 Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Patients Status COMPLETED Phase NA
NCT01640067 Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE1
NCT01639391 Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study Status COMPLETED Phase NA
NCT01609283 A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT01592084 Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis Status COMPLETED Phase N/A
NCT01583088 Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation Status TERMINATED Phase PHASE3
NCT01569958 Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral Sclerosis Status UNKNOWN Phase PHASE2
NCT01565395 Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) Status WITHDRAWN Phase PHASE2